Zymeworks (ZYME) Appoints Nancy Davidson to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ANT
4. LLY
5. TSLA
6. META
7. FICO
8. ACCV
9. CART
10. SPCX

Go back to Zymeworks (ZYME) Appoints Nancy Davidson to its Board

Zymeworks Announces New Director Nominee

October 16, 2023 4:30 PM EDT

VANCOUVER, British Columbia, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel multifunctional biotherapeutics, today announced that its board of directors will nominate Dr. Nancy Davidson for election to its board of directors at the Companys upcoming annual general meeting of stockholders to be held on December 7, 2023.

As the Company continues to execute on our strategy to support the approval and commercialization of zanidatamab while targeting five IND filings for new product candidates before the end of 2027, we are pleased to announce a... More